DNA PLOIDY OF THE PRIMARY TUMOR AS A PREDICTOR OF ENDOCRINE SENSITIVITY IN BREAST-CANCER
In 75 patients with breast cancer we have correlated DNA ploidy of the primary tumour with response to systemic endocrine therapy and with survival. Diploid tumours were compared with tetraploid and other aneuploid tumours; there was no difference for response to endocrine therapy or survival.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Affiliations: CRC NOTTIGHAM,NOTTINGHAM NG5 1PB,ENGLAND. UNIV WALES COLL CARDIFF,COLL MED,TENOVUS INST,CARDIFF CF1 3NS,S GLAM,WALES.
Publication date: January 1, 1993
More about this publication?
- The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites